Drug intelligence / Profile preview

fructus aurantii immaturus

Development stage
Unknown
Modality
Small Molecules
Administration
Oral (decoction)
01

Overview

Fructus aurantii immaturus is the dried unripe fruit of Citrus aurantium L. or its cultivars (including Citrus sinensis Osbeck), widely used in Traditional Chinese Medicine (TCM) under the name Zhi Shi. It is typically harvested between May and June and can be used raw or processed (e.g., stir-baked). The herb contains active compounds such as flavonoids (notably neohesperidin and naringin), alkaloids, volatile oils, and coumarins. In TCM practice, it is valued for its ability to promote the flow of qi (vital energy), relieve gastrointestinal stagnation, resolve phlegm, alleviate abdominal distension and pain due to heat retention or damp-heat conditions, treat constipation and diarrhea with tenesmus, as well as address prolapse of rectum or uterus[1][2][4]. Modern research has shown that extracts from fructus aurantii immaturus have anti-inflammatory effects on intestinal inflammation by modulating gut microbiota[1], may possess antidepressant activity through modulation of neurotransmitters like 5-HT/DA/NE and cytokines such as IL-1β/TNF-α[5], exhibit antioxidant properties[1], regulate intestinal motility[1], protect gastric mucosa[1], improve blood supply to organs including heart/kidney/brain[4], among other effects.

Other names
Zhi ShiAurantii Fructus Immaturusimmature bitter orange枳实
02

Targets

JUN (Transcription factor Jun)VEGFA (Vascular endothelial growth factor A)ERKAKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)CASP3 (Caspase-3)

Beyond the preview

Go deeper on fructus aurantii immaturus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fructus aurantii immaturus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call